Rahul Sasané

1.9k total citations
56 papers, 1.5k citations indexed

About

Rahul Sasané is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Pathology and Forensic Medicine. According to data from OpenAlex, Rahul Sasané has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 14 papers in Economics and Econometrics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Rahul Sasané's work include Attention Deficit Hyperactivity Disorder (18 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Multiple Sclerosis Research Studies (10 papers). Rahul Sasané is often cited by papers focused on Attention Deficit Hyperactivity Disorder (18 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Multiple Sclerosis Research Studies (10 papers). Rahul Sasané collaborates with scholars based in United States, United Kingdom and Netherlands. Rahul Sasané's co-authors include Paul Hodgkins, Philip Asherson, Ron Akehurst, Kathleen Beusterien, J. J. Sandra Kooij, Michael Huß, Carolyn Harley, Leslie Montejano, Willemijn M. Meijer and Jay Meyer and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Rahul Sasané

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rahul Sasané United States 23 744 358 239 221 208 56 1.5k
Janet M. Grubber United States 24 202 0.3× 237 0.7× 65 0.3× 152 0.7× 110 0.5× 64 2.4k
Pablo Reyes Colombia 22 511 0.7× 773 2.2× 63 0.3× 80 0.4× 154 0.7× 51 2.1k
Engilbert Sigurðsson Iceland 23 418 0.6× 135 0.4× 24 0.1× 188 0.9× 52 0.3× 86 1.5k
Laura Horsfall United Kingdom 22 195 0.3× 215 0.6× 157 0.7× 151 0.7× 41 0.2× 36 2.0k
Helge Müller Germany 18 426 0.6× 355 1.0× 45 0.2× 290 1.3× 22 0.1× 76 1.4k
Jorge Mauriño Spain 22 444 0.6× 31 0.1× 351 1.5× 224 1.0× 144 0.7× 99 1.4k
Michael Sweeney United States 22 587 0.8× 143 0.4× 96 0.4× 543 2.5× 28 0.1× 42 1.8k
Dana DiBenedetti United States 20 371 0.5× 68 0.2× 170 0.7× 192 0.9× 70 0.3× 70 1.5k
Philippos Gourzis Greece 21 458 0.6× 120 0.3× 180 0.8× 262 1.2× 24 0.1× 80 1.4k
Sally Mannix United States 17 329 0.4× 32 0.1× 83 0.3× 107 0.5× 134 0.6× 33 731

Countries citing papers authored by Rahul Sasané

Since Specialization
Citations

This map shows the geographic impact of Rahul Sasané's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Sasané with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Sasané more than expected).

Fields of papers citing papers by Rahul Sasané

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Sasané. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Sasané. The network helps show where Rahul Sasané may publish in the future.

Co-authorship network of co-authors of Rahul Sasané

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Sasané. A scholar is included among the top collaborators of Rahul Sasané based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Sasané. Rahul Sasané is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mantri, Sneha, et al.. (2024). A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups. Patient Preference and Adherence. Volume 18. 1919–1928. 2 indexed citations
3.
Arcona, Steve, et al.. (2023). Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease. ClinicoEconomics and Outcomes Research. Volume 15. 309–319. 3 indexed citations
4.
Song, Yan, E Jian‐Yu, Rahul Sasané, et al.. (2023). Treatment Patterns and Healthcare Resource Use in Medicare Beneficiaries with Parkinson’s Disease. ClinicoEconomics and Outcomes Research. Volume 15. 631–643.
5.
Arcona, Steve, et al.. (2022). Dopamine agonist monotherapy utilization in patients with Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 8. 100173–100173. 1 indexed citations
6.
Navaratnam, Prakash, et al.. (2021). Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review. Clinical Parkinsonism & Related Disorders. 6. 100125–100125. 4 indexed citations
7.
Zhou, Huanxue, Kristen Johnson, John J. Ko, et al.. (2016). Real World Relapse Rates of Glatiramer Acetate Patients Switching to Fingolimod or Interferon Beta-1a Versus Remaining on Glatiramer Acetate (P6.181). Neurology. 86(16_supplement). 1 indexed citations
8.
Wicks, Paul, et al.. (2016). The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis. BMC Research Notes. 9(1). 434–434. 28 indexed citations
9.
10.
Wicks, Paul, et al.. (2015). Preferred Features of Oral Treatments and Predictors of Non-Adherence: Two Web-Based Choice Experiments in Multiple Sclerosis Patients. SHILAP Revista de lepidopterología. 4(1). e6–e6. 35 indexed citations
11.
Vollmer, Timothy, Lynn Huynh, Caroline Kelley, et al.. (2015). Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review. Neurological Sciences. 37(2). 165–179. 61 indexed citations
12.
Vollmer, Timothy, James Signorovitch, Lynn Huynh, et al.. (2015). The natural history of brain volume loss among patients with multiple sclerosis: A systematic literature review and meta-analysis. Journal of the Neurological Sciences. 357(1-2). 8–18. 64 indexed citations
13.
Nafees, Beenish, Juliana Setyawan, Andrew Lloyd, et al.. (2014). Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries. European Child & Adolescent Psychiatry. 23(12). 1189–1200. 25 indexed citations
14.
Matheson, Lauren, Philip Asherson, Ian Chi Kei Wong, et al.. (2013). Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study. BMC Health Services Research. 13(1). 184–184. 87 indexed citations
15.
Hodgkins, Paul, et al.. (2012). Persistence, Augmentation, and Consumption of Long-Acting Medications in ADHD Patients. The American Journal of Managed Care. 4. 6 indexed citations
16.
Lawson, Kenneth A., Michael Johnsrud, Paul Hodgkins, Rahul Sasané, & M. Lynn Crismon. (2012). Utilization Patterns of Stimulants in ADHD in the Medicaid Population: A Retrospective Analysis of Data from the Texas Medicaid Program. Clinical Therapeutics. 34(4). 944–956.e4. 38 indexed citations
17.
Lloyd, Andrew, et al.. (2011). Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: Heterogeneity in parent preferences. International Journal of Technology Assessment in Health Care. 27(3). 215–223. 16 indexed citations
18.
Lloyd, Andrew, Paul Hodgkins, Rahul Sasané, et al.. (2011). Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations. Patient. 4(4). 247–257. 16 indexed citations
19.
Meyer, Jay, et al.. (2005). Patterns and Effectiveness of Lipid-Lowering Therapies in a Managed Care Environment. Value in Health. 8(5). 601–612. 19 indexed citations
20.
Joish, Vijay N., Gary Donaldson, Gary M. Oderda, et al.. (2005). The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Current Medical Research and Opinion. 21(4). 535–543. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet M. Grubber Breakdown of academic impact, for papers by Pablo Reyes Breakdown of academic impact, for papers by Engilbert Sigurðsson Breakdown of academic impact, for papers by Laura Horsfall Breakdown of academic impact, for papers by Helge Müller Breakdown of academic impact, for papers by Jorge Mauriño Breakdown of academic impact, for papers by Michael Sweeney Breakdown of academic impact, for papers by Dana DiBenedetti Breakdown of academic impact, for papers by Philippos Gourzis Breakdown of academic impact, for papers by Sally Mannix
Rankless by CCL
2026